Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system

Código QR

Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system

Kostrzewski et al. introduce an in vitro microphysiological model of non-alcoholic steatohepatitis (NASH), consisting of co-cultured primary human liver cells. The authors characterised the transcriptomic, inflammatory and fibrotic phenotype of the model and show that major features of NASH can be r...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomasz Kostrzewski, Sophie Snow, Anya Lindström Battle, Samantha Peel, Zahida Ahmad, Jayati Basak, Manasa Surakala, Aurelie Bornot, Julia Lindgren, Maria Ryaboshapkina, Maryam Clausen, Daniel Lindén, Christian Maass, Lucy May Young, Adam Corrigan, Lorna Ewart, David Hughes
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/2fe033487d4045ff86e6fb36c7f3e8b7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A Novel Microphysiological Colon Platform to Decipher Mechanisms Driving Human Intestinal PermeabilitySummary
por: Athanasia Apostolou, et al.
Publicado: (2021)

Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies
por: Christian Maass, et al.
Publicado: (2018)

A combined microphysiological-computational omics approach in dietary protein evaluation
por: Paulus G. M. Jochems, et al.
Publicado: (2020)

Modeling early stage atherosclerosis in a primary human vascular microphysiological system
por: Xu Zhang, et al.
Publicado: (2020)

Three dimensional and microphysiological bone marrow models detect in vivo positive compounds
por: Rhiannon David, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)

An Immunocompetent Microphysiological System to Simultaneously Investigate Effects of Anti-Tumor Natural Killer Cells on Tumor and Cardiac Microtissues
por: Oanh T. P. Nguyen, et al.
Publicado: (2021)

Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system
por: Tomoki Imaoka, et al.
Publicado: (2021)

Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021)

Cathepsin D regulates lipid metabolism in murine steatohepatitis
por: Tom Houben, et al.
Publicado: (2017)

Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system
por: Marie Shinohara, et al.
Publicado: (2021)

Bile acids contribute to the development of non-alcoholic steatohepatitis in mice
por: Justine Gillard, et al.
Publicado: (2022)

Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice
por: Joost Willebrords, et al.
Publicado: (2017)

NEALKOHOLNI STEATOHEPATITIS PRI OTROKU − PRAKTIČNI PRISTOP S PREDSTAVITVIJO PRIMERA
por: Ana Šinkovec, et al.
Publicado: (2021)

Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
por: Arthur C. Sletten, et al.
Publicado: (2021)

The development of nonalcoholic steatohepatitis is subjected to breeder dependent variation in guinea pigs
por: D. H. Ipsen, et al.
Publicado: (2021)

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
por: Hiroki Sakamoto, et al.
Publicado: (2021)

β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model
por: Zigmond E, et al.
Publicado: (2014)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
por: Kawanaka M, et al.
Publicado: (2013)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
por: Ana Šinkovec, et al.
Publicado: (2021)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang J, et al.
Publicado: (2021)

Clodronate, an inhibitor of the vesicular nucleotide transporter, ameliorates steatohepatitis and acute liver injury
por: Nao Hasuzawa, et al.
Publicado: (2021)

Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
por: Yadi Li, et al.
Publicado: (2021)

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
por: Alia Hadefi, et al.
Publicado: (2021)

Cargo proteins in extracellular vesicles: potential for novel therapeutics in non-alcoholic steatohepatitis
por: Jimin Kim, et al.
Publicado: (2021)

Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
por: Kristin Alexandra Dayton, et al.
Publicado: (2021)

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis
por: Guangyong Sun, et al.
Publicado: (2021)

The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017
por: Mimi Zhai, et al.
Publicado: (2021)

Author Correction: Loss of SNORA73 reprograms cellular metabolism and protects against steatohepatitis
por: Arthur C. Sletten, et al.
Publicado: (2021)

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
por: Daniel Cabrera, et al.
Publicado: (2017)

Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice
por: Kook Hwan Kim, et al.
Publicado: (2018)

Rat model of nonalcoholic steatohepatitis created by methionine and choline deficiency: biochemical and histological analyses
por: Seki A, et al.
Publicado: (2011)

Quantitative, noninvasive MRI characterization of disease progression in a mouse model of non-alcoholic steatohepatitis
por: Philip A. Waghorn, et al.
Publicado: (2021)

Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis
por: Peter M. Abuja, et al.
Publicado: (2021)

Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma
por: Sophie Jacques, et al.
Publicado: (2021)

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling
por: Jessie Qiaoyi Liang, et al.
Publicado: (2018)

β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
por: Masuko Kobori, et al.
Publicado: (2014)

Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation
por: Zhiqiang Li, et al.
Publicado: (2021)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Tae Hyung Kim, et al.
Publicado: (2021)

Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
por: Hegazy MA, et al.
Publicado: (2019)